Beta Drugs Limited (NSE:BETA)
India flag India · Delayed Price · Currency is INR
1,894.00
+40.25 (2.17%)
At close: Jun 4, 2025

Beta Drugs Market Cap

Beta Drugs has a market cap or net worth of 18.50 billion as of June 6, 2025. Its market cap has increased by 61.68% in one year.

Market Cap
18.50B
Enterprise Value
18.41B
Revenue
3.35B
Ranking
n/a
PE Ratio
45.11
Stock Price
1,894.00

Market Cap Chart

Since October 25, 2017, Beta Drugs's market cap has increased from 915.98M to 18.50B, an increase of 1,919.49%. That is a compound annual growth rate of 48.36%.

History

DateMarket Cap% Change
Jun 6, 202518.50B-4.22%
Dec 31, 202419.31B36.67%
Dec 29, 202314.13B107.04%
Dec 30, 20226.83B10.89%
Dec 31, 20216.16B497.76%
Dec 31, 20201.03B56.85%
Dec 27, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Reliance Industries 18.34T
HDFC Bank 15.16T
Tata Consultancy Services 12.24T
Bharti Airtel 11.20T
ICICI Bank 10.41T
State Bank of India 7,256.16B
Infosys 6,481.26B
Life Insurance Corporation of India 6,071.05B
Market Cap Rankings